Advancement of CREATES and FAIR Drug Pricing Acts Marks Step Toward Boosting Competition and Transparency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement praising lawmakers on the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee for taking up and advancing […]
This week, Big Pharma giant AbbVie announced plans to acquire drug maker Allergan in a $63 billion merger. AbbVie, the maker of top-selling drug in the U.S. Humira, notched over $32 billion in revenue in 2018, while Allergan, best known for manufacturing Botox, made nearly $16 billion in annual revenue. What do AbbVie and Allergan […]
Encourages Senate Panel to Further Strengthen Drug Price Package with REMEDY and FAIR Drug Pricing Acts For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today ahead of a U.S. Senate Health, Education, Labor and Pensions (HELP) Committee legislative markup of its drug […]
Report Finds Significant Catastrophic Liability for Drug Makers Benefits Seniors, Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) said Tuesday that a new study from Oliver Wyman analyzing different cost sharing scenarios underscores the critical need to hold Big Pharma accountable in Medicare Part […]
Current Trade Agreement Could Hamper Generic and Biosimilar Competition For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) sent a letter to members of Congress today detailing concerns with the proposed U.S.-Mexico-Canada Agreement (USMCA) and asking lawmakers to address those concerns to protect American patients. “CSRxP […]
Greater List Price Transparency Will Help Crack Down on Big Pharma’s Price-Gouging For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today ahead of a U.S. Senate Health, Education, Labor and Pensions (HELP) Committee legislative hearing Tuesday to encourage the committee to take […]
Drug Makers Intensify Blame Game While Seeking to Avoid Accountability For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today issued a statement after fresh evidence that PhRMA and BIO, the principal trade groups representing Big Pharma, have ramped-up their blame game tactics targeting others in […]
Poll Finds U.S. Adults Blame Drug Makers for Rising Prices, Oppose Administration’s Rebate Rule and See Value in PBMs For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on a new national survey that found an overwhelming 84 percent of Americans want […]
Bipartisan CREATES, FAIR Drug Pricing and REMEDY Acts Will Deliver Relief for American Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today issued a statement on comments submitted to Chairman Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) of the U.S. Senate […]
For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of two days of hearings before the U.S. Senate Committee on the Judiciary Subcommittee on Intellectual Property on the “State of Patent Eligibility in America.” “At a time when one in four […]